For its fourth quarter of 2024, CRISPR booked revenue of just under $36 million. That was well under the more than $201 million the company earned in the same period of 2023. On the bottom line, ...
Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and complex class of genetic ...
Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...
New Vision on MSN14h
Magoola says cancer treatment invention awarded US patentKAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...
Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...
Gene editing is already being used to treat a handful of rare genetic diseases; however, most therapies involve breaking or ...
Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback